|
|
|
|
LEADER |
01178pam a2200241 a 4500 |
001 |
2503766 |
003 |
GR-PaULI |
005 |
20211026131730.0 |
008 |
920409s1995 nyua b 001 0 eng c |
952 |
|
|
|0 0
|1 0
|2 ddc
|4 0
|6 571_967000000000000_INT
|7 0
|9 329806
|a LISP
|b LISP
|c BSC
|d 2021-10-26
|i 127396
|l 0
|o 571.967 INT
|p 025000286285
|r 2021-10-26 00:00:00
|t 1
|w 2021-10-26
|y BK15
|
999 |
|
|
|c 184591
|d 184591
|
020 |
|
|
|a 1850706484
|
040 |
|
|
|a DNLM/DLC
|c GR-PaULI
|d
|b gre
|e AACR2
|
082 |
0 |
4 |
|a 571.967
|2 23
|
245 |
0 |
0 |
|a Intravenous immunoglobulin therapy :
|b clinical benefits and future prospects /
|c edited M. D. Kazatchkine.
|
260 |
|
|
|a New York ;
|a London :
|b Parthenon,
|c c1995.
|
300 |
|
|
|a 136 σ. :
|b εικ. ;
|c 24 εκ.
|
500 |
|
|
|a This volume summarizes the reports that were presented and discussions that took place during an international roundtable meeting held in Barcelona in June 1994.
|
504 |
|
|
|a Περιλαμβάνει βιβλιογραφικές παραπομπές και ευρετήριο.
|
650 |
|
4 |
|a Ανοσοσφαιρίνες
|9 137684
|
700 |
1 |
|
|a Kazatchkine, M.
|9 188241
|e επιμελητής.
|q (Michel)
|
942 |
|
|
|2 ddc
|c BK15
|
998 |
|
|
|c ΜΠΟΥΡΑΣ
|d 2021-10
|